TFEB and tauopathy: Increased expression of TFEB in astrocytes in the PS19 tauopathy mouse model reduced tau pathology and decreased levels of astrocyte gliosis, although increased expression of astrocytic TFEB in a more rapidly progressive tauopathy mouse model did not reduce tau pathology.